Insider Purchase: Chief Legal & Emrg Biz Officer of $GEVO Buys 12,500 Shares

By: Quiver InsiderRadar, Automated

Posted: 7 hours ago / Aug. 25, 2026 12:02 a.m. UTC

David Michael Kettner, the Chief Legal & Emrg Biz Officer of $GEVO, bought 12,500 shares of the company on 08-21-2026 for an estimated $19,368. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings of this class of stock by approximately 4.7%. Following this trade, they now own 276,788 shares of this class of $GEVO stock.

$GEVO Insider Trading Activity

$GEVO insiders have traded $GEVO stock on the open market 26 times in the past 6 months. Of those trades, 2 have been purchases and 24 have been sales.

Here’s a breakdown of recent trading of $GEVO stock by insiders over the last 6 months:

• PATRICK R. GRUBER has made 0 purchases and 3 sales selling 591,674 shares for an estimated $922,819.
• CHRISTOPHER MICHAEL RYAN (President & COO) has made 0 purchases and 4 sales selling 252,693 shares for an estimated $568,411.
• GARY W. MIZE sold 107,100 shares for an estimated $250,078
• PAUL D BLOOM (CEO) has made 0 purchases and 3 sales selling 142,020 shares for an estimated $231,498.
• OLUWAGBEMILEKE YUSUF AGIRI (CFO) has made 0 purchases and 3 sales selling 113,209 shares for an estimated $172,761.
• ANDREW SHAFER (Chief Mktg Cust & Brnd Officer) has made 0 purchases and 5 sales selling 58,760 shares for an estimated $109,321.
• KIMBERLY T BOWRON (Chief of Staff) has made 0 purchases and 3 sales selling 50,828 shares for an estimated $82,075.
• JAMES J BARBER purchased 50,000 shares for an estimated $77,000
• LINDSAY CLINTON FITZGERALD (Chief Public Affairs Officer) sold 20,000 shares for an estimated $50,124
• DAVID MICHAEL KETTNER (Chief Legal & Emrg Biz Officer) purchased 12,500 shares for an estimated $19,368
• DAVAAJARGAL GENDENJAMTS (VP Acctg and Treasurer) sold 4,293 shares for an estimated $6,118

To track insider transactions, check out Quiver Quantitative’s insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$GEVO Hedge Fund Activity

We have seen 77 institutional investors add shares of $GEVO stock to their portfolio, and 81 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• STATE STREET CORP added 4,364,606 shares (+48.1%) to their portfolio in Q2 2026, for an estimated $6,546,909
• GOLDMAN SACHS GROUP INC removed 2,372,480 shares (-61.2%) from their portfolio in Q2 2026, for an estimated $3,558,720
• INVESCO LTD. added 2,226,428 shares (+66.5%) to their portfolio in Q2 2026, for an estimated $3,339,642
• RENAISSANCE TECHNOLOGIES LLC removed 2,215,194 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $3,322,791
• UBS GROUP AG added 1,160,992 shares (+53.1%) to their portfolio in Q2 2026, for an estimated $1,741,488
• BLACKROCK, INC. added 1,007,913 shares (+5.8%) to their portfolio in Q2 2026, for an estimated $1,511,869
• CITADEL ADVISORS LLC removed 853,378 shares (-41.3%) from their portfolio in Q2 2026, for an estimated $1,280,067

To track hedge funds’ stock portfolios, check out Quiver Quantitative’s institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$GEVO Revenue

$GEVO had revenues of $46.5M in Q2 2026. This is an increase of 7.11% from the same period in the prior year.

You can track GEVO financials on Quiver Quantitative’s GEVO stock page.

You can access data on GEVO stock through the Quiver Quantitative API.

$GEVO Price Targets

Multiple analysts have issued price targets for $GEVO recently. We have seen 2 analysts offer price targets for $GEVO in the last 6 months, with a median target of $2.75.

Here are some recent targets:

• Manav Gupta from UBS set a target price of $2.0 on 05/22/2026
• Jeff Grampp from Northland Capital Markets set a target price of $3.5 on 04/16/2026

This article is not financial advice. See Quiver Quantitative’s disclaimers for more information.